遇见数据集

A Phase 2b, Randomized, Multi-Dose Efficacy,Safety Study of the Oral Factor Xa Inhibitor DU-176b Versus Enoxaparin Sodium for Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty (STARS J-2)

收藏
DataCite Commons2025-02-10 更新2026-05-07 收录
官方服务:

资源简介:

The objective of this study is to compare the efficacy, safety of DU-176b 30mg or DU-176b 15mg versus enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total hip arthroplasty.

提供机构:
Vivli
创建时间:
2018-12-17
二维码
社区交流群
二维码
科研交流群
商业服务